Clinical Trial Details

EORTC-1410p

Back to Clinical Trials Database

Evaluation of ABT-414 in Children with High Grade Gliomas (Main study: ABT-414 alone or ABT-414 plus temozolomide versus lomustine for recurrent glioblastoma: a randomized phase II study of the EORTC Brain Tumor Group)

Study documentation

Trial Status All trial activities ended
Dates Date of activation: 10-Jan-2017
Date Step1 close: 15-Jan-2019
Date Step2 close: 15-Jan-2019
Data management at EORTC Yes
Design Phase 2
Not randomized / N.A.
Targeted Sample size All Groups: 15
Treatment
Study Staff
Type of cancer
Participating groups
Protocol summary http://clinicaltrials.gov/study/NCT02343406
NCT number NCT02343406
EudraCT 2014-004438-24